P
Pacific Biosciences PACB
$1.96
−0.51%
Nov 13
1W
1M
3M
6M
1Y
3Y
5Y
Activities
Key indicators
Sales
+4%
$161M over 12 months
Net margin
−82%
Low
High
Volatility
94%
Calm
Choppy
Bars: against the 7 close companies.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
Earnings release
The day the company publishes its quarterly accounts: revenue, profit, and often its outlook. The price sometimes moves sharply that day, in either direction. Over the long term, what matters is the trend of profits from one quarter to the next, not the reaction of the day.
Posts
No posts about PACB yet.
About Pacific Biosciences of California, Inc. Common Stock
PacBio designs and sells HiFi long-read DNA sequencing systems such as Revio and Vega, used by researchers and increasingly clinical labs. It earns money from instrument sales, from consumables (the chemistry and flow cells customers buy to run each sample), and from service contracts. The company is still unprofitable and funds itself with cash and convertible notes.